System and method to regulate ultrafiltration

Patent metadata

Field	Value
Publication number	US-2016331884-A1
Application number	US-201615190553-A
Country	US
Kind code	A1
Filing date	Jun 23, 2016
Priority date	Sep 30, 2009
Publication date	Nov 17, 2016
Grant date	—

Abstract

A medical device system including a physiological sensor and ultrafiltration unit senses a physiological signal in a patient and computes a fluid status measurement of the patient using the physiological signal. Ultrafiltration therapy is delivered to the patient according to a therapy delivery control parameter established in response to the fluid status measurement.

First claim

What is claimed is:

1 . A method for use in a medical device system comprising a physiological sensor and an ultrafiltration therapy delivery device, the method comprising:
sensing at least one physiological signal in a patient; computing a fluid status measurement of the patient using the at least one physiological signal; delivering ultrafiltration therapy to the patient according to a therapy delivery control parameter; and establishing a setting for the control parameter in response to the fluid status measurement; wherein the at least one physiological parameter includes an ECG signal.

2 . The method of claim 1 , further comprising:
storing a target range of the fluid status measurement; comparing the fluid status measurement to the target range; and establishing the control parameter in response to the comparison.

3 . The method of claim 2 , further comprising determining a trend of previously computed fluid status measurements and computing the target range using the trend.

4 . The method of claim 2 , wherein establishing the control parameter comprises establishing a flow rate in proportion to a difference between the fluid status measurement and the target range.

5 . The method of claim 2 , further comprising storing a target level of the fluid status measurement,
performing ultrafiltration until a current fluid status measurement reaches the target level.

6 . The method of claim 1 , further comprising storing a therapy delivery threshold;
comparing the fluid status measurement to the therapy delivery threshold and detecting a need for ultrafiltration therapy in response to the comparison; enabling the ultrafiltration therapy delivery device in response to detecting the need.

7 . The method of claim 1 , further comprising:
computing an updated fluid status measurement during delivery of ultrafiltration therapy; and determining an adjusted setting for the control parameter in response to the updated fluid status measurement.

8 . A computer readable medium storing a set of instructions which cause a programmable processor implemented in a medical device system comprising a physiological sensor and an ultrafiltration unit to perform a method comprising:
sensing at least one physiological signal in a patient; computing a fluid status measurement of the patient using the physiological signal; delivering ultrafiltration therapy to the patient according to a therapy delivery control parameter; and establishing a setting for the control parameter in response to the fluid status measurement; wherein the at least one physiological signal includes an ECG signal.

9 . The computer readable medium of claim 8 , wherein the method further comprises determining a trend of previously computed fluid status measurements and computing the target range using the trend.

10 . The method of claim 1 , further comprising sensing at least a second physiological signal in the patient; wherein the first physiological signal and second physiological signal are different signals;
computing a second fluid status measurement of the patient using the second physiological signal; and wherein the step of establishing a setting for the control parameter in response to the fluid status measurement comprises establishing a setting for the control parameter in response to the first and second fluid status measurements.

11 . The method of claim 10 , wherein the second physiological signal is selected from the group consisting of intraventricular pressure, thoracic impedance, oxygen, blood urea nitrogen, serum creatine, serum electrolytes, blood glucose, thyroid stimulating hormone, intracardia right ventricular pressure signals, transthoracic signals, or any combination thereof.

12 . The method of claim 2 , further comprising sensing at least a second physiological signal in the patient; wherein the first physiological signal and second physiological signal are different signals; computing a second fluid status measurement of the patient using the second physiological signal; and wherein the target range is an index computed using a combination of the at least two fluid status measurements.

13 . The method of claim 1 , wherein the control parameter is a setting which enables or disables ultrafiltration.

14 . The method of claim 1 , wherein the control parameter is pressure across an ultrafiltration membrane.

15 . The method of claim 4 , wherein establishing a flow rate comprises controlling one or more valves to control the flow rate.

16 . The method of claim 7 , further comprising stopping ultrafiltration therapy when the updated fluid status measurement is within a target range.

17 . The method of claim 1 , wherein the ultrafiltration therapy delivery device automatically delivers ultrafiltration therapy to the patient when the fluid status measurement is outside of a target range.

18 . The method of claim 1 , wherein the ultrafiltration therapy delivery device generates a notification when the fluid status measurement is outside of a target range.

19 . The computer readable medium of claim 8 , wherein the method further comprises sensing at least a second physiological signal of the patient; computing a second fluid status measurement of the patient using the second physiological signal; and
wherein the step of establishing a setting for the control parameter in response to the fluid status measurement comprises establishing a setting for the control parameter in response to the first and second fluid status measurements.

20 . The computer readable medium of claim 19 , wherein the second physiological signal is selected from the group consisting of intraventricular pressure, thoracic impedance, oxygen, blood urea nitrogen, serum creatine, serum electrolytes, blood glucose, thyroid stimulating hormone, intracardia right ventricular pressure signals, transthoracic signals, or any combination thereof.

Assignees

• Medtronic Inc

Inventors

• Sigg Daniel C
• Audet Sarah Anne
• Bennett Tommy D
• Warkentin Dwight H

Classifications

• A61M2230/30

  Blood pressure (A61M2230/04 takes precedence) · CPC title

• A61M2230/04

  Heartbeat characteristics, e.g. ECG, blood pressure modulation · CPC title

• A61M2205/18

  with alarm · CPC title

• A61M2230/005

  Parameter used as control input for the apparatus · CPC title

• A61M2205/3523

  using telemetric means · CPC title